agree, this is what we discussed last quarter.
but, human and animal derived revenue is up over 550% in 1 year.
this revenue is very much going in the right direction very quickly
they did mention last quarter that they intended to slash costs, and that isn't showing up at present.
if I was a shareholder in for the longer term, I would put substantial pressure on them to address cost reductions as they have said "
if they did that, and revenue kept growing at these levels or close to , you have a good business starting to emerge.
keep ramping up revenue, but ramp costs down at same time.
obviously they will be looking at cutting quite a few staff numbers, and sales go to incentive payments etc as previously discussed.
Ann: Preliminary Report & Annual Report to shareholders, page-7
Add to My Watchlist
What is My Watchlist?